review Open AccessTop 1% cited
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
Alimentary Pharmacology & Therapeutics · 2011 · Vol. 34(3) · pp. 274–285
Gregory C. Vernon✉(Inova Fairfax Hospital)Ancha Baranova(Inova Health System)Zobair M. Younossi(Inova Health System)
Abstract
Non-alcoholic fatty liver disease is the most common cause of elevated liver enzymes. Within the NAFLD spectrum, only NASH progresses to cirrhosis and hepatocellular carcinoma. With the growing epidemic of obesity, the prevalence and impact of NAFLD continues to increase, making NASH potentially the most common cause of advanced liver disease in coming decades.
Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseLiver Diseases and ImmunitySteatohepatitisFatty liverMedicineInternal medicineCirrhosisLiver biopsyEpidemiologyAlcoholic liver diseaseMetabolic syndromeHepatocellular carcinoma
MeSH terms
AdultBiopsyFatty LiverHumansPrognosisRisk FactorsPrevalenceNon-alcoholic Fatty Liver Disease
Citations
3,085
FWCI
92.61
field-weighted impact
References
121
Percentile
100%
vs. same field & year
Citations per year
Cited by
Assessment of cases of fatty liver disease using USG and CT scan
International Journal of Radiology and Diagnostic Imaging · 2021 · 0 citations
Diagnostic and therapeutic challenges in Non-Alcoholic Fatty Liver Disease (NAFLD)
International Journal of Advanced Research in Medicine · 2025 · 0 citations
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
Hepatology · 2023 · 2,046 citations
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Journal of Hepatology · 2016 · 4,795 citations
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
Hepatology · 2014 · 2,228 citations
Mechanisms of Insulin Action and Insulin Resistance
Physiological Reviews · 2018 · 2,790 citations
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
Journal of Hepatology · 2015 · 1,853 citations
Molecular pathways of nonalcoholic fatty liver disease development and progression
Cellular and Molecular Life Sciences · 2018 · 588 citations
References
Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡
Hepatology · 2006 · 2,303 citations
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆
Gastroenterology · 1999 · 3,359 citations
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Hepatology · 1999 · 1,133 citations
Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma
Gastroenterology · 2002 · 1,434 citations
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Gastroenterology · 2005 · 2,883 citations
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Nature Genetics · 2008 · 3,326 citations
the Incidence and Risk Factors of Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis
Hepatology · 2010 · 1,287 citations
Prevalence of and Risk Factors for Nonalcoholic Fatty Liver Disease: The Dionysos Nutrition and Liver Study * #
Hepatology · 2005 · 1,265 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
